Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endocarditis, Bacterial | 34 | 2024 | 455 | 2.650 |
Why?
|
Bacteremia | 22 | 2021 | 962 | 2.170 |
Why?
|
Staphylococcal Infections | 37 | 2017 | 1400 | 2.050 |
Why?
|
Endocarditis | 15 | 2024 | 350 | 1.750 |
Why?
|
Diabetic Foot | 11 | 2018 | 355 | 1.680 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 6 | 2021 | 687 | 1.420 |
Why?
|
Staphylococcus aureus | 17 | 2017 | 1451 | 1.080 |
Why?
|
Daptomycin | 6 | 2021 | 73 | 1.020 |
Why?
|
Methicillin Resistance | 8 | 2008 | 198 | 0.870 |
Why?
|
Mycoses | 7 | 2008 | 376 | 0.810 |
Why?
|
Prosthesis-Related Infections | 6 | 2014 | 538 | 0.800 |
Why?
|
Anti-Bacterial Agents | 44 | 2022 | 7181 | 0.800 |
Why?
|
Fosfomycin | 1 | 2021 | 25 | 0.790 |
Why?
|
Cross Infection | 19 | 2009 | 1416 | 0.770 |
Why?
|
Vancomycin | 15 | 2019 | 501 | 0.730 |
Why?
|
Heart Valve Prosthesis | 19 | 2023 | 1488 | 0.640 |
Why?
|
Streptococcal Infections | 12 | 2004 | 638 | 0.620 |
Why?
|
Nafcillin | 1 | 2017 | 25 | 0.610 |
Why?
|
Cefazolin | 1 | 2017 | 96 | 0.580 |
Why?
|
Central Nervous System Bacterial Infections | 1 | 2016 | 8 | 0.570 |
Why?
|
Whipple Disease | 1 | 2016 | 19 | 0.570 |
Why?
|
Candidiasis | 13 | 2008 | 366 | 0.540 |
Why?
|
Anti-Infective Agents | 5 | 2023 | 972 | 0.500 |
Why?
|
Communicable Diseases | 6 | 2024 | 880 | 0.500 |
Why?
|
Methicillin | 6 | 2017 | 59 | 0.500 |
Why?
|
Heart Valves | 3 | 2014 | 291 | 0.500 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 547 | 0.490 |
Why?
|
Travel Medicine | 6 | 2015 | 84 | 0.490 |
Why?
|
Communicable Disease Control | 2 | 2020 | 857 | 0.490 |
Why?
|
Patient Care | 1 | 2020 | 640 | 0.480 |
Why?
|
Liver Transplantation | 8 | 2008 | 2119 | 0.470 |
Why?
|
Antifungal Agents | 8 | 2008 | 730 | 0.460 |
Why?
|
Surgery, Plastic | 1 | 2020 | 624 | 0.450 |
Why?
|
Travel | 8 | 2016 | 788 | 0.430 |
Why?
|
Anthrax | 2 | 2023 | 88 | 0.430 |
Why?
|
Bacillus anthracis | 2 | 2023 | 123 | 0.430 |
Why?
|
Amphotericin B | 4 | 2008 | 137 | 0.420 |
Why?
|
Vancomycin Resistance | 2 | 2009 | 128 | 0.390 |
Why?
|
Streptococcus anginosus | 2 | 2011 | 24 | 0.350 |
Why?
|
Debridement | 7 | 2018 | 492 | 0.350 |
Why?
|
Meningitis | 3 | 2023 | 216 | 0.320 |
Why?
|
Penicillins | 6 | 2019 | 380 | 0.320 |
Why?
|
Community-Acquired Infections | 5 | 2008 | 465 | 0.320 |
Why?
|
Dengue Virus | 3 | 2016 | 204 | 0.320 |
Why?
|
Staphylococcal Skin Infections | 1 | 2008 | 75 | 0.310 |
Why?
|
Heart Valve Diseases | 6 | 2004 | 1073 | 0.300 |
Why?
|
Foreign Bodies | 2 | 2011 | 399 | 0.300 |
Why?
|
Abscess | 2 | 2016 | 607 | 0.300 |
Why?
|
Coagulase | 4 | 2003 | 54 | 0.300 |
Why?
|
Dengue | 3 | 2016 | 256 | 0.290 |
Why?
|
Heart, Artificial | 2 | 2002 | 102 | 0.290 |
Why?
|
Antibiotic Prophylaxis | 3 | 2012 | 639 | 0.290 |
Why?
|
Respiratory Tract Infections | 4 | 2004 | 961 | 0.280 |
Why?
|
Bacterial Infections | 9 | 2004 | 1401 | 0.270 |
Why?
|
Diarrhea | 6 | 1996 | 1348 | 0.270 |
Why?
|
Heart Atria | 2 | 2011 | 1357 | 0.260 |
Why?
|
Catheters, Indwelling | 4 | 2009 | 426 | 0.250 |
Why?
|
Oxacillin | 2 | 2017 | 42 | 0.240 |
Why?
|
Defibrillators, Implantable | 3 | 2021 | 1440 | 0.240 |
Why?
|
Anthrax Vaccines | 1 | 2023 | 14 | 0.240 |
Why?
|
Fluconazole | 6 | 2008 | 146 | 0.240 |
Why?
|
Catheterization, Central Venous | 3 | 2008 | 514 | 0.230 |
Why?
|
Antitoxins | 1 | 2023 | 81 | 0.230 |
Why?
|
Staphylococcus | 3 | 2000 | 155 | 0.220 |
Why?
|
Humans | 169 | 2024 | 744343 | 0.220 |
Why?
|
Osteomyelitis | 7 | 2009 | 402 | 0.220 |
Why?
|
Heart-Assist Devices | 2 | 2003 | 1194 | 0.210 |
Why?
|
Gentamicins | 5 | 2009 | 255 | 0.210 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Serologic Tests | 3 | 2013 | 374 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.200 |
Why?
|
Antiretroviral Therapy, Highly Active | 6 | 2010 | 1873 | 0.200 |
Why?
|
Beauty | 1 | 2021 | 42 | 0.200 |
Why?
|
Gram-Positive Cocci | 1 | 2000 | 9 | 0.190 |
Why?
|
Ampicillin | 3 | 1997 | 139 | 0.190 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 3 | 2010 | 138 | 0.190 |
Why?
|
Middle Aged | 81 | 2019 | 213383 | 0.190 |
Why?
|
Pacemaker, Artificial | 2 | 2003 | 816 | 0.180 |
Why?
|
Diabetes Complications | 2 | 1999 | 1359 | 0.180 |
Why?
|
Cilastatin | 2 | 1997 | 11 | 0.180 |
Why?
|
Sulbactam | 2 | 1997 | 26 | 0.180 |
Why?
|
Imipenem | 2 | 1997 | 38 | 0.180 |
Why?
|
Equipment Contamination | 3 | 1998 | 185 | 0.180 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2004 | 567 | 0.180 |
Why?
|
Viridans Streptococci | 1 | 2019 | 15 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Coxiella burnetii | 1 | 2000 | 37 | 0.180 |
Why?
|
Q Fever | 1 | 2000 | 37 | 0.180 |
Why?
|
Carrier State | 2 | 2004 | 518 | 0.170 |
Why?
|
Streptococcus pneumoniae | 1 | 2004 | 714 | 0.170 |
Why?
|
Gram-Positive Bacterial Infections | 3 | 2009 | 341 | 0.160 |
Why?
|
Skin Diseases, Infectious | 1 | 1999 | 74 | 0.160 |
Why?
|
Male | 86 | 2019 | 350118 | 0.160 |
Why?
|
Cosmetic Techniques | 1 | 2020 | 135 | 0.160 |
Why?
|
Clostridium Infections | 2 | 1996 | 548 | 0.160 |
Why?
|
Microbial Sensitivity Tests | 12 | 2009 | 1877 | 0.150 |
Why?
|
Sepsis | 5 | 2011 | 2593 | 0.150 |
Why?
|
Hepatitis B | 3 | 2013 | 695 | 0.150 |
Why?
|
Pneumonia, Bacterial | 2 | 2016 | 316 | 0.150 |
Why?
|
Thienamycins | 1 | 1997 | 28 | 0.150 |
Why?
|
Drug Resistance, Microbial | 6 | 2003 | 862 | 0.150 |
Why?
|
Home Infusion Therapy | 1 | 1996 | 19 | 0.150 |
Why?
|
Bone Diseases, Infectious | 1 | 2016 | 18 | 0.140 |
Why?
|
Drug Therapy, Combination | 10 | 2010 | 6489 | 0.140 |
Why?
|
Cryptococcosis | 2 | 2008 | 101 | 0.140 |
Why?
|
Osteoarthropathy, Secondary Hypertrophic | 1 | 1996 | 13 | 0.140 |
Why?
|
Pneumocystis | 1 | 1996 | 57 | 0.140 |
Why?
|
Leptin | 4 | 2010 | 1599 | 0.140 |
Why?
|
Japanese Encephalitis Vaccines | 1 | 2015 | 6 | 0.140 |
Why?
|
Risk Factors | 26 | 2020 | 72290 | 0.140 |
Why?
|
Encephalitis, Japanese | 1 | 2015 | 12 | 0.140 |
Why?
|
Adult | 66 | 2023 | 214055 | 0.130 |
Why?
|
Aspergillosis | 2 | 1995 | 235 | 0.130 |
Why?
|
Rabies Vaccines | 1 | 2015 | 31 | 0.130 |
Why?
|
Pseudomonas Infections | 4 | 2009 | 613 | 0.130 |
Why?
|
Endemic Diseases | 2 | 2013 | 182 | 0.130 |
Why?
|
Diagnostic Errors | 2 | 2013 | 1257 | 0.130 |
Why?
|
Foot Diseases | 1 | 1997 | 143 | 0.130 |
Why?
|
Rabies | 1 | 2015 | 61 | 0.130 |
Why?
|
Histocytochemistry | 1 | 2016 | 719 | 0.130 |
Why?
|
Infusions, Intra-Arterial | 1 | 1995 | 234 | 0.130 |
Why?
|
Immunization Schedule | 2 | 2015 | 221 | 0.130 |
Why?
|
Female | 82 | 2023 | 380194 | 0.130 |
Why?
|
Crisis Intervention | 1 | 2015 | 105 | 0.130 |
Why?
|
Fluoroquinolones | 3 | 2003 | 310 | 0.130 |
Why?
|
Thiazolidinediones | 2 | 2010 | 476 | 0.130 |
Why?
|
Aortic Valve | 2 | 2004 | 1922 | 0.120 |
Why?
|
Enterobacteriaceae Infections | 2 | 2009 | 187 | 0.120 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1996 | 249 | 0.120 |
Why?
|
Postoperative Complications | 8 | 2009 | 15295 | 0.120 |
Why?
|
Fungemia | 4 | 2008 | 53 | 0.120 |
Why?
|
Antibodies, Bacterial | 1 | 2000 | 1470 | 0.120 |
Why?
|
Tropical Medicine | 1 | 2014 | 49 | 0.120 |
Why?
|
Dengue Vaccines | 1 | 2013 | 14 | 0.120 |
Why?
|
Drug Therapy | 1 | 1997 | 497 | 0.120 |
Why?
|
Streptococcus | 5 | 2000 | 197 | 0.110 |
Why?
|
Clindamycin | 3 | 1987 | 139 | 0.110 |
Why?
|
Pseudallescheria | 1 | 1992 | 3 | 0.110 |
Why?
|
Rifampin | 2 | 1986 | 315 | 0.110 |
Why?
|
Aged | 49 | 2016 | 163280 | 0.110 |
Why?
|
Protease Inhibitors | 1 | 1997 | 791 | 0.110 |
Why?
|
Pseudomonas aeruginosa | 3 | 2009 | 1219 | 0.110 |
Why?
|
Fever | 5 | 2011 | 1616 | 0.110 |
Why?
|
Enterococcus | 3 | 2004 | 157 | 0.110 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 1994 | 264 | 0.110 |
Why?
|
Gram-Negative Bacteria | 2 | 2007 | 270 | 0.110 |
Why?
|
Vaccination | 7 | 2016 | 3278 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 657 | 0.100 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 1997 | 1873 | 0.100 |
Why?
|
Candida | 4 | 2008 | 172 | 0.100 |
Why?
|
Brain | 4 | 2016 | 26385 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1035 | 0.100 |
Why?
|
Food, Formulated | 1 | 1992 | 109 | 0.100 |
Why?
|
Patient Admission | 2 | 2004 | 1380 | 0.100 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2001 | 1462 | 0.100 |
Why?
|
Parenteral Nutrition, Total | 1 | 1992 | 302 | 0.100 |
Why?
|
Bronchography | 1 | 2011 | 74 | 0.100 |
Why?
|
Boston | 9 | 2015 | 9313 | 0.100 |
Why?
|
Fusobacterium | 1 | 2011 | 54 | 0.100 |
Why?
|
Premedication | 6 | 1993 | 258 | 0.100 |
Why?
|
Insulin Resistance | 5 | 2010 | 3864 | 0.100 |
Why?
|
Feces | 6 | 1998 | 1401 | 0.100 |
Why?
|
Cryptococcus neoformans | 2 | 2008 | 119 | 0.090 |
Why?
|
Incidence | 6 | 2016 | 20947 | 0.090 |
Why?
|
Urinary Tract Infections | 7 | 2000 | 788 | 0.090 |
Why?
|
Mycetoma | 1 | 1990 | 12 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15540 | 0.090 |
Why?
|
Brain Abscess | 2 | 2011 | 118 | 0.090 |
Why?
|
Octoxynol | 1 | 2009 | 77 | 0.090 |
Why?
|
Wound Healing | 2 | 2018 | 2785 | 0.090 |
Why?
|
Penicillin Resistance | 6 | 1989 | 84 | 0.090 |
Why?
|
Bacteriolysis | 1 | 2009 | 51 | 0.090 |
Why?
|
Length of Stay | 3 | 2016 | 6309 | 0.080 |
Why?
|
Postprandial Period | 1 | 2010 | 292 | 0.080 |
Why?
|
Colony Count, Microbial | 1 | 2009 | 331 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.080 |
Why?
|
Post-Exposure Prophylaxis | 2 | 2022 | 102 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12959 | 0.080 |
Why?
|
Disease Outbreaks | 4 | 2013 | 1772 | 0.080 |
Why?
|
Heart Diseases | 2 | 2021 | 2788 | 0.080 |
Why?
|
Pulmonary Valve | 1 | 1992 | 437 | 0.080 |
Why?
|
Microbial Viability | 1 | 2009 | 234 | 0.080 |
Why?
|
Endocarditis, Subacute Bacterial | 1 | 1987 | 8 | 0.080 |
Why?
|
Lipodystrophy | 1 | 2009 | 147 | 0.080 |
Why?
|
Cohort Studies | 9 | 2017 | 40561 | 0.080 |
Why?
|
Intensive Care Units | 5 | 2008 | 3679 | 0.080 |
Why?
|
Physicians, Primary Care | 1 | 2014 | 591 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2011 | 374 | 0.070 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2007 | 232 | 0.070 |
Why?
|
Pneumonia | 6 | 2008 | 2133 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 1998 | 1458 | 0.070 |
Why?
|
United States | 14 | 2023 | 69872 | 0.070 |
Why?
|
Time Factors | 10 | 2018 | 40075 | 0.070 |
Why?
|
Candida albicans | 3 | 2008 | 394 | 0.070 |
Why?
|
Mass Screening | 2 | 2013 | 5255 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2014 | 3923 | 0.070 |
Why?
|
Hospitalization | 6 | 2016 | 10262 | 0.070 |
Why?
|
Fusidic Acid | 1 | 1986 | 15 | 0.070 |
Why?
|
Bronchi | 1 | 2011 | 840 | 0.070 |
Why?
|
Wound Infection | 1 | 2009 | 242 | 0.070 |
Why?
|
Sulfamethoxazole | 1 | 1986 | 53 | 0.070 |
Why?
|
Trimethoprim | 1 | 1986 | 91 | 0.070 |
Why?
|
Double-Blind Method | 8 | 2008 | 12026 | 0.070 |
Why?
|
Antibodies, Viral | 2 | 2016 | 3176 | 0.070 |
Why?
|
HIV-1 | 3 | 2010 | 6939 | 0.070 |
Why?
|
Viral Vaccines | 6 | 1971 | 636 | 0.070 |
Why?
|
Hormones, Ectopic | 1 | 2005 | 40 | 0.070 |
Why?
|
Multivariate Analysis | 6 | 2009 | 12245 | 0.070 |
Why?
|
Counseling | 1 | 2013 | 1523 | 0.070 |
Why?
|
Organ Transplantation | 1 | 1995 | 1139 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2016 | 4560 | 0.060 |
Why?
|
Listeriosis | 1 | 1986 | 149 | 0.060 |
Why?
|
Heart Block | 1 | 1986 | 410 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2011 | 761 | 0.060 |
Why?
|
Staphylococcus epidermidis | 4 | 1987 | 117 | 0.060 |
Why?
|
Retrospective Studies | 14 | 2016 | 77449 | 0.060 |
Why?
|
Lung Diseases, Fungal | 1 | 1985 | 122 | 0.060 |
Why?
|
Personnel, Hospital | 2 | 1998 | 283 | 0.060 |
Why?
|
Fenofibrate | 1 | 2005 | 88 | 0.060 |
Why?
|
Yellow Fever Vaccine | 2 | 2016 | 37 | 0.060 |
Why?
|
Asia | 2 | 2016 | 610 | 0.060 |
Why?
|
Surgical Wound Infection | 9 | 1995 | 1540 | 0.060 |
Why?
|
Adipose Tissue | 3 | 2008 | 3279 | 0.060 |
Why?
|
Arthritis, Infectious | 2 | 2005 | 367 | 0.060 |
Why?
|
Bone and Bones | 1 | 1995 | 2575 | 0.060 |
Why?
|
Renal Dialysis | 2 | 2009 | 1786 | 0.060 |
Why?
|
Prospective Studies | 12 | 2016 | 53288 | 0.060 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 2 | 1998 | 253 | 0.060 |
Why?
|
Enterobacter | 1 | 2003 | 46 | 0.060 |
Why?
|
Bacteria | 4 | 2012 | 2114 | 0.060 |
Why?
|
Aged, 80 and over | 15 | 2013 | 57776 | 0.060 |
Why?
|
Prostheses and Implants | 2 | 2007 | 1387 | 0.060 |
Why?
|
Leukapheresis | 1 | 2003 | 131 | 0.050 |
Why?
|
Patient Compliance | 1 | 2013 | 2684 | 0.050 |
Why?
|
Case-Control Studies | 6 | 2009 | 21746 | 0.050 |
Why?
|
Rubella virus | 4 | 1970 | 11 | 0.050 |
Why?
|
Suppuration | 2 | 2012 | 56 | 0.050 |
Why?
|
Diet, Mediterranean | 1 | 2009 | 700 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2009 | 719 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 3 | 1999 | 143 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1997 | 3336 | 0.050 |
Why?
|
Sterilization | 1 | 2003 | 133 | 0.050 |
Why?
|
Bioterrorism | 1 | 2022 | 143 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13284 | 0.050 |
Why?
|
Creatinine | 3 | 2009 | 1919 | 0.050 |
Why?
|
Hospitals, Teaching | 2 | 1999 | 1179 | 0.050 |
Why?
|
Population Surveillance | 3 | 2004 | 2616 | 0.050 |
Why?
|
Risk Assessment | 3 | 2018 | 23338 | 0.050 |
Why?
|
Hernia, Femoral | 2 | 1992 | 17 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2003 | 315 | 0.050 |
Why?
|
Substance-Related Disorders | 3 | 2015 | 4258 | 0.050 |
Why?
|
Aerosols | 1 | 2023 | 625 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3528 | 0.050 |
Why?
|
Comorbidity | 2 | 2013 | 10388 | 0.050 |
Why?
|
Rickettsia rickettsii | 1 | 2000 | 5 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2008 | 2015 | 0.050 |
Why?
|
Ehrlichia | 1 | 2000 | 7 | 0.050 |
Why?
|
Hypoglycemic Agents | 2 | 2010 | 2872 | 0.050 |
Why?
|
Lipomatosis | 1 | 1981 | 112 | 0.050 |
Why?
|
DNA, Bacterial | 2 | 1996 | 1465 | 0.050 |
Why?
|
Escherichia coli Infections | 2 | 2003 | 532 | 0.040 |
Why?
|
Echocardiography | 3 | 1994 | 5102 | 0.040 |
Why?
|
Osteoarthritis | 1 | 2007 | 1036 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2232 | 0.040 |
Why?
|
Hypertriglyceridemia | 1 | 2003 | 293 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 322 | 0.040 |
Why?
|
Cushing Syndrome | 1 | 1981 | 249 | 0.040 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2002 | 493 | 0.040 |
Why?
|
Ceftazidime | 1 | 1999 | 69 | 0.040 |
Why?
|
Survival Analysis | 3 | 2006 | 10252 | 0.040 |
Why?
|
Treatment Outcome | 12 | 2008 | 63114 | 0.040 |
Why?
|
Rectum | 2 | 1994 | 904 | 0.040 |
Why?
|
Spinal Cord Compression | 1 | 1981 | 235 | 0.040 |
Why?
|
Canada | 1 | 2004 | 2065 | 0.040 |
Why?
|
Genetic Variation | 1 | 1994 | 6544 | 0.040 |
Why?
|
Adolescent | 18 | 2016 | 85781 | 0.040 |
Why?
|
Corynebacterium | 3 | 1988 | 47 | 0.040 |
Why?
|
Mucormycosis | 1 | 1999 | 97 | 0.040 |
Why?
|
Hernia, Inguinal | 2 | 1992 | 210 | 0.040 |
Why?
|
Vitamin E | 1 | 2003 | 869 | 0.040 |
Why?
|
Child | 19 | 2023 | 77709 | 0.040 |
Why?
|
Breast | 3 | 1993 | 1969 | 0.040 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 1994 | 546 | 0.040 |
Why?
|
Home Care Services | 2 | 1996 | 606 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 1999 | 252 | 0.040 |
Why?
|
Cephalosporins | 1 | 1999 | 204 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2004 | 1133 | 0.040 |
Why?
|
Soft Tissue Infections | 1 | 1999 | 155 | 0.040 |
Why?
|
Cross Reactions | 1 | 2000 | 841 | 0.040 |
Why?
|
Cluster Analysis | 2 | 1996 | 2715 | 0.040 |
Why?
|
Device Removal | 1 | 2003 | 656 | 0.040 |
Why?
|
Switzerland | 1 | 1998 | 255 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3870 | 0.040 |
Why?
|
Orthotic Devices | 1 | 1998 | 128 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5985 | 0.040 |
Why?
|
Diagnostic Tests, Routine | 1 | 2003 | 783 | 0.040 |
Why?
|
Lung | 1 | 1996 | 9856 | 0.040 |
Why?
|
Chest Pain | 1 | 2004 | 1114 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2008 | 2569 | 0.040 |
Why?
|
Hospital Charges | 1 | 1999 | 362 | 0.040 |
Why?
|
Carbenicillin | 1 | 1976 | 15 | 0.040 |
Why?
|
Kidney | 2 | 2009 | 7186 | 0.040 |
Why?
|
Young Adult | 8 | 2016 | 56430 | 0.040 |
Why?
|
Preoperative Care | 2 | 2004 | 2250 | 0.040 |
Why?
|
Hospital Mortality | 3 | 2008 | 5317 | 0.040 |
Why?
|
Prevalence | 5 | 2013 | 15226 | 0.040 |
Why?
|
Drug Administration Schedule | 4 | 2007 | 4933 | 0.030 |
Why?
|
Yellow Fever | 1 | 2016 | 53 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1782 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6256 | 0.030 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1979 | 675 | 0.030 |
Why?
|
Blood Platelet Disorders | 1 | 1976 | 58 | 0.030 |
Why?
|
Rubella | 4 | 1970 | 48 | 0.030 |
Why?
|
Environmental Microbiology | 1 | 1996 | 46 | 0.030 |
Why?
|
Infection Control | 3 | 2001 | 966 | 0.030 |
Why?
|
Lincomycin | 1 | 1975 | 6 | 0.030 |
Why?
|
Immunocompromised Host | 2 | 2009 | 847 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2647 | 0.030 |
Why?
|
Morbidity | 2 | 2001 | 1769 | 0.030 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1995 | 29 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1676 | 0.030 |
Why?
|
Cytotoxins | 1 | 1996 | 153 | 0.030 |
Why?
|
Streptococcus agalactiae | 1 | 1997 | 375 | 0.030 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1994 | 15 | 0.030 |
Why?
|
Lactams | 2 | 1987 | 156 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2023 | 2016 | 0.030 |
Why?
|
Dental Care for Disabled | 2 | 1991 | 20 | 0.030 |
Why?
|
Muromonab-CD3 | 1 | 1994 | 96 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 1994 | 191 | 0.030 |
Why?
|
Africa | 1 | 2016 | 673 | 0.030 |
Why?
|
Bacteria, Aerobic | 1 | 1994 | 25 | 0.030 |
Why?
|
Coronary Angiography | 2 | 2004 | 4577 | 0.030 |
Why?
|
Follow-Up Studies | 9 | 2013 | 39050 | 0.030 |
Why?
|
Bacteria, Anaerobic | 1 | 1994 | 68 | 0.030 |
Why?
|
Restriction Mapping | 1 | 1994 | 878 | 0.030 |
Why?
|
Bacterial Typing Techniques | 1 | 1994 | 256 | 0.030 |
Why?
|
Disinfection | 1 | 1996 | 191 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 1996 | 499 | 0.030 |
Why?
|
Herpes Simplex | 3 | 1982 | 470 | 0.030 |
Why?
|
Drug Synergism | 5 | 1988 | 1792 | 0.030 |
Why?
|
Hospital Units | 1 | 1994 | 141 | 0.030 |
Why?
|
Child, Preschool | 11 | 2016 | 41006 | 0.030 |
Why?
|
Casts, Surgical | 1 | 1994 | 178 | 0.030 |
Why?
|
Caribbean Region | 1 | 2013 | 194 | 0.030 |
Why?
|
Liver Function Tests | 1 | 1994 | 528 | 0.030 |
Why?
|
Catheterization | 4 | 2003 | 1470 | 0.030 |
Why?
|
Bacterial Toxins | 2 | 1996 | 931 | 0.030 |
Why?
|
Consultants | 1 | 2013 | 53 | 0.030 |
Why?
|
Antidiarrheals | 1 | 2012 | 45 | 0.030 |
Why?
|
Injections | 1 | 2015 | 840 | 0.030 |
Why?
|
Typhoid-Paratyphoid Vaccines | 1 | 2012 | 39 | 0.030 |
Why?
|
Body Composition | 3 | 2009 | 2401 | 0.030 |
Why?
|
Cross-Sectional Studies | 6 | 2013 | 25043 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2013 | 159 | 0.030 |
Why?
|
Cyclosporine | 1 | 1995 | 786 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2001 | 1076 | 0.030 |
Why?
|
Program Evaluation | 1 | 2001 | 2488 | 0.030 |
Why?
|
Brazil | 1 | 2016 | 1270 | 0.030 |
Why?
|
Prognosis | 6 | 1995 | 29063 | 0.030 |
Why?
|
Molecular Biology | 1 | 1996 | 596 | 0.030 |
Why?
|
Drug Stability | 1 | 1992 | 291 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2013 | 305 | 0.030 |
Why?
|
Cytarabine | 1 | 1973 | 692 | 0.030 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 1971 | 28 | 0.030 |
Why?
|
Mumps virus | 1 | 1971 | 24 | 0.030 |
Why?
|
Graft Rejection | 2 | 1995 | 4397 | 0.020 |
Why?
|
Solutions | 1 | 1992 | 426 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1537 | 0.020 |
Why?
|
Smallpox Vaccine | 2 | 1971 | 80 | 0.020 |
Why?
|
Friends | 1 | 2012 | 154 | 0.020 |
Why?
|
Placebos | 4 | 2008 | 1676 | 0.020 |
Why?
|
Disease Management | 1 | 2002 | 2459 | 0.020 |
Why?
|
Mumps | 2 | 1971 | 64 | 0.020 |
Why?
|
Tacrolimus | 1 | 1995 | 743 | 0.020 |
Why?
|
Adiponectin | 2 | 2010 | 1100 | 0.020 |
Why?
|
Escherichia coli | 1 | 2003 | 4217 | 0.020 |
Why?
|
Measles Vaccine | 1 | 1971 | 76 | 0.020 |
Why?
|
HIV Infections | 4 | 2009 | 16718 | 0.020 |
Why?
|
Hepatic Veins | 1 | 1991 | 112 | 0.020 |
Why?
|
Cefonicid | 1 | 1990 | 7 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1995 | 732 | 0.020 |
Why?
|
Furazolidone | 1 | 1970 | 5 | 0.020 |
Why?
|
Encephalitis | 3 | 1982 | 423 | 0.020 |
Why?
|
Hand | 1 | 1996 | 884 | 0.020 |
Why?
|
Hospital Costs | 1 | 1997 | 985 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2003 | 3386 | 0.020 |
Why?
|
Fresh Water | 1 | 1990 | 83 | 0.020 |
Why?
|
India | 1 | 2016 | 2197 | 0.020 |
Why?
|
Cardiac Tamponade | 1 | 1991 | 173 | 0.020 |
Why?
|
Medical Records | 1 | 1995 | 1413 | 0.020 |
Why?
|
Coronary Disease | 1 | 2004 | 6077 | 0.020 |
Why?
|
Hepatitis B virus | 1 | 2013 | 513 | 0.020 |
Why?
|
Pneumonia, Aspiration | 1 | 1990 | 145 | 0.020 |
Why?
|
Medical Records Department, Hospital | 1 | 2008 | 6 | 0.020 |
Why?
|
Drug Costs | 1 | 1997 | 1105 | 0.020 |
Why?
|
Cephalothin | 2 | 1979 | 36 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2009 | 380 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2001 | 2291 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1995 | 820 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2007 | 1420 | 0.020 |
Why?
|
Gram-Positive Bacteria | 1 | 2009 | 184 | 0.020 |
Why?
|
Tobramycin | 1 | 1988 | 69 | 0.020 |
Why?
|
Urine | 2 | 2000 | 370 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2001 | 5391 | 0.020 |
Why?
|
Infant | 8 | 2012 | 35136 | 0.020 |
Why?
|
Vena Cava Filters | 1 | 1991 | 252 | 0.020 |
Why?
|
Cefamandole | 1 | 1987 | 9 | 0.020 |
Why?
|
Metabolism | 1 | 2009 | 196 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 216 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 1990 | 494 | 0.020 |
Why?
|
Virus Diseases | 1 | 1973 | 711 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6234 | 0.020 |
Why?
|
Foreign-Body Reaction | 1 | 1988 | 157 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1992 | 2557 | 0.020 |
Why?
|
Knee Joint | 1 | 1996 | 1680 | 0.020 |
Why?
|
Internationality | 1 | 2013 | 1003 | 0.020 |
Why?
|
Patient Transfer | 1 | 1994 | 761 | 0.020 |
Why?
|
Exercise | 1 | 2003 | 5615 | 0.020 |
Why?
|
Reoperation | 2 | 1994 | 4201 | 0.020 |
Why?
|
Israel | 1 | 2009 | 796 | 0.020 |
Why?
|
Bacterial Adhesion | 1 | 1988 | 316 | 0.020 |
Why?
|
Radiography | 2 | 2009 | 7023 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
Infusions, Parenteral | 2 | 1991 | 419 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13695 | 0.020 |
Why?
|
Aminoglycosides | 3 | 1987 | 162 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1994 | 1855 | 0.020 |
Why?
|
Antigens, Fungal | 1 | 1985 | 70 | 0.020 |
Why?
|
Logistic Models | 3 | 2008 | 13408 | 0.020 |
Why?
|
Heparin | 1 | 1992 | 1637 | 0.020 |
Why?
|
Resistin | 1 | 2005 | 170 | 0.020 |
Why?
|
Aspirin | 1 | 1976 | 3282 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 1990 | 1285 | 0.020 |
Why?
|
Neutropenia | 2 | 2003 | 895 | 0.010 |
Why?
|
Rubella Vaccine | 4 | 1970 | 22 | 0.010 |
Why?
|
Self Care | 1 | 2009 | 786 | 0.010 |
Why?
|
Recurrence | 3 | 2001 | 8340 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2008 | 2029 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 2 | 1991 | 1066 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15165 | 0.010 |
Why?
|
Cholera | 1 | 1970 | 785 | 0.010 |
Why?
|
Vidarabine | 2 | 1982 | 345 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 525 | 0.010 |
Why?
|
Cardiology | 1 | 1994 | 1668 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2009 | 1814 | 0.010 |
Why?
|
Malaria | 1 | 2012 | 1239 | 0.010 |
Why?
|
Infant, Newborn | 4 | 2011 | 25625 | 0.010 |
Why?
|
Inflammation | 2 | 2012 | 10638 | 0.010 |
Why?
|
Antibody Formation | 3 | 1973 | 1402 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1983 | 517 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
Societies, Medical | 1 | 1994 | 3743 | 0.010 |
Why?
|
Myelography | 1 | 1981 | 69 | 0.010 |
Why?
|
Family | 1 | 2012 | 3147 | 0.010 |
Why?
|
Age Factors | 5 | 2009 | 18370 | 0.010 |
Why?
|
Cauda Equina | 1 | 1981 | 42 | 0.010 |
Why?
|
Triglycerides | 1 | 2009 | 2454 | 0.010 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 272 | 0.010 |
Why?
|
Hypertrophy | 1 | 2003 | 569 | 0.010 |
Why?
|
Corynebacterium Infections | 1 | 1980 | 27 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1994 | 3848 | 0.010 |
Why?
|
Drug Combinations | 1 | 1986 | 1959 | 0.010 |
Why?
|
Blood Cells | 1 | 2003 | 309 | 0.010 |
Why?
|
Encephalitis, Arbovirus | 1 | 1980 | 3 | 0.010 |
Why?
|
Health Behavior | 1 | 2012 | 2636 | 0.010 |
Why?
|
Microbiology | 1 | 2001 | 72 | 0.010 |
Why?
|
Epidural Space | 1 | 1981 | 124 | 0.010 |
Why?
|
Financial Support | 1 | 2001 | 115 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 604 | 0.010 |
Why?
|
Developing Countries | 1 | 2013 | 2815 | 0.010 |
Why?
|
Sex Factors | 5 | 1986 | 10397 | 0.010 |
Why?
|
Penicillin G Procaine | 1 | 1979 | 4 | 0.010 |
Why?
|
Nerve Compression Syndromes | 1 | 1981 | 160 | 0.010 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1999 | 60 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 1994 | 12354 | 0.010 |
Why?
|
Shock, Septic | 1 | 1986 | 775 | 0.010 |
Why?
|
Penicillin V | 1 | 1979 | 18 | 0.010 |
Why?
|
Penicillin G | 1 | 1979 | 42 | 0.010 |
Why?
|
Heart Failure | 3 | 1998 | 10900 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 1988 | 1736 | 0.010 |
Why?
|
Erythromycin | 1 | 1979 | 120 | 0.010 |
Why?
|
Plasmids | 1 | 1984 | 2307 | 0.010 |
Why?
|
Regression Analysis | 2 | 2003 | 6459 | 0.010 |
Why?
|
Atrophy | 1 | 2003 | 1583 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2003 | 789 | 0.010 |
Why?
|
Heart Murmurs | 1 | 1978 | 94 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1979 | 552 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 2124 | 0.010 |
Why?
|
Pilot Projects | 1 | 2010 | 8324 | 0.010 |
Why?
|
Clinical Trials as Topic | 6 | 1987 | 7913 | 0.010 |
Why?
|
Markov Chains | 1 | 2001 | 969 | 0.010 |
Why?
|
Endonucleases | 1 | 1980 | 380 | 0.010 |
Why?
|
Hemagglutination Inhibition Tests | 3 | 1971 | 77 | 0.010 |
Why?
|
Abdomen | 1 | 2003 | 1118 | 0.010 |
Why?
|
Leukocytosis | 1 | 1978 | 247 | 0.010 |
Why?
|
Administration, Oral | 2 | 1987 | 3913 | 0.010 |
Why?
|
Eating | 1 | 2003 | 1536 | 0.010 |
Why?
|
Frail Elderly | 1 | 2001 | 693 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6580 | 0.010 |
Why?
|
Embolism | 1 | 1998 | 408 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1381 | 0.010 |
Why?
|
Antioxidants | 1 | 2003 | 1663 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1678 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3507 | 0.010 |
Why?
|
Hip Prosthesis | 1 | 1981 | 917 | 0.010 |
Why?
|
Serotyping | 1 | 1975 | 338 | 0.010 |
Why?
|
Life Expectancy | 1 | 2001 | 1184 | 0.010 |
Why?
|
Electrocardiography | 1 | 1987 | 6442 | 0.010 |
Why?
|
Streptococcus pyogenes | 1 | 1976 | 289 | 0.010 |
Why?
|
Hip Joint | 1 | 1981 | 1002 | 0.010 |
Why?
|
Algorithms | 2 | 2004 | 13881 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1978 | 518 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1994 | 768 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 1994 | 290 | 0.010 |
Why?
|
DNA, Viral | 1 | 1980 | 2225 | 0.010 |
Why?
|
Nucleosides | 1 | 1973 | 138 | 0.010 |
Why?
|
Capillaries | 1 | 1976 | 773 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12720 | 0.010 |
Why?
|
Enterotoxins | 1 | 1994 | 368 | 0.010 |
Why?
|
Peritoneal Dialysis | 1 | 1973 | 146 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2007 | 3537 | 0.010 |
Why?
|
Ceftriaxone | 1 | 1993 | 168 | 0.010 |
Why?
|
Antibodies | 2 | 1971 | 2460 | 0.010 |
Why?
|
Odds Ratio | 1 | 2004 | 9849 | 0.010 |
Why?
|
Mumps Vaccine | 1 | 1971 | 17 | 0.010 |
Why?
|
Risk | 2 | 1999 | 9687 | 0.010 |
Why?
|
Data Collection | 1 | 2001 | 3341 | 0.010 |
Why?
|
Smallpox | 1 | 1971 | 45 | 0.010 |
Why?
|
Herpes Zoster | 1 | 1973 | 264 | 0.010 |
Why?
|
Animals | 3 | 2015 | 168757 | 0.010 |
Why?
|
Rheumatic Fever | 1 | 1990 | 71 | 0.010 |
Why?
|
Hospitals | 1 | 2004 | 3952 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2003 | 3297 | 0.010 |
Why?
|
Oral Hygiene | 1 | 1991 | 126 | 0.010 |
Why?
|
Poliomyelitis | 1 | 1971 | 103 | 0.010 |
Why?
|
Risk Management | 1 | 1994 | 571 | 0.010 |
Why?
|
Vibrio | 1 | 1970 | 39 | 0.010 |
Why?
|
Interferons | 1 | 1973 | 706 | 0.010 |
Why?
|
Myocardial Revascularization | 1 | 1994 | 841 | 0.010 |
Why?
|
Tetracycline | 1 | 1970 | 214 | 0.010 |
Why?
|
Measles | 1 | 1971 | 168 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2005 | 4256 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1971 | 758 | 0.010 |
Why?
|
Methods | 1 | 1969 | 1129 | 0.010 |
Why?
|
Brain Diseases | 1 | 1978 | 1563 | 0.010 |
Why?
|
Teicoplanin | 1 | 1988 | 27 | 0.010 |
Why?
|
Equipment Failure | 1 | 1991 | 578 | 0.000 |
Why?
|
Body Temperature | 1 | 1971 | 777 | 0.000 |
Why?
|
Infusions, Intravenous | 1 | 1993 | 2274 | 0.000 |
Why?
|
Proteins | 1 | 2003 | 6103 | 0.000 |
Why?
|
Blood Pressure | 1 | 2003 | 8554 | 0.000 |
Why?
|
Sodium Chloride | 1 | 1969 | 625 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1990 | 20129 | 0.000 |
Why?
|
Glycopeptides | 1 | 1988 | 224 | 0.000 |
Why?
|
Simplexvirus | 2 | 1981 | 802 | 0.000 |
Why?
|
Bacterial Vaccines | 1 | 1969 | 403 | 0.000 |
Why?
|
Exercise Test | 1 | 1994 | 2074 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2004 | 19905 | 0.000 |
Why?
|
American Heart Association | 1 | 1990 | 1056 | 0.000 |
Why?
|
Cardiomyopathies | 1 | 1978 | 1912 | 0.000 |
Why?
|
Hypothermia, Induced | 1 | 1991 | 752 | 0.000 |
Why?
|
Seasons | 2 | 1969 | 1493 | 0.000 |
Why?
|
Random Allocation | 1 | 1990 | 2429 | 0.000 |
Why?
|
Diet | 1 | 2003 | 7939 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1990 | 1677 | 0.000 |
Why?
|
Mastectomy, Segmental | 1 | 1990 | 956 | 0.000 |
Why?
|
Thrombolytic Therapy | 1 | 1994 | 2161 | 0.000 |
Why?
|
Hemorrhage | 1 | 1976 | 3461 | 0.000 |
Why?
|
Immunization | 1 | 1969 | 1256 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9583 | 0.000 |
Why?
|
Lymph Node Excision | 1 | 1990 | 1261 | 0.000 |
Why?
|
Tricuspid Valve | 1 | 1986 | 403 | 0.000 |
Why?
|
Neuralgia | 1 | 1969 | 570 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1990 | 1170 | 0.000 |
Why?
|
Mastectomy | 1 | 1990 | 1793 | 0.000 |
Why?
|
Acyclovir | 1 | 1982 | 272 | 0.000 |
Why?
|
Tuberculosis, Osteoarticular | 1 | 1981 | 26 | 0.000 |
Why?
|
Cerebrospinal Fluid | 1 | 1984 | 534 | 0.000 |
Why?
|
Guanine | 1 | 1982 | 274 | 0.000 |
Why?
|
Drug Hypersensitivity | 1 | 1989 | 884 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1986 | 2373 | 0.000 |
Why?
|
Quality of Life | 1 | 2001 | 12804 | 0.000 |
Why?
|
Body Weight | 1 | 1970 | 4669 | 0.000 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1978 | 148 | 0.000 |
Why?
|
Biopsy | 2 | 1981 | 6756 | 0.000 |
Why?
|
Arthroplasty | 1 | 1981 | 305 | 0.000 |
Why?
|
Mitral Valve | 1 | 1986 | 1491 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1991 | 2376 | 0.000 |
Why?
|
Aneurysm, Infected | 1 | 1978 | 85 | 0.000 |
Why?
|
Haemophilus Infections | 1 | 1977 | 95 | 0.000 |
Why?
|
Haemophilus influenzae | 1 | 1977 | 171 | 0.000 |
Why?
|
Consciousness | 1 | 1981 | 572 | 0.000 |
Why?
|
Kinetics | 1 | 1983 | 6473 | 0.000 |
Why?
|
Peptides | 1 | 1987 | 4409 | 0.000 |
Why?
|
Micrococcus | 1 | 1973 | 13 | 0.000 |
Why?
|
Serratia | 1 | 1973 | 14 | 0.000 |
Why?
|
Bacillus | 1 | 1973 | 77 | 0.000 |
Why?
|
Klebsiella Infections | 1 | 1973 | 138 | 0.000 |
Why?
|
Software | 1 | 1986 | 4443 | 0.000 |
Why?
|
Tooth Extraction | 1 | 1973 | 222 | 0.000 |
Why?
|
Anticoagulants | 1 | 1986 | 4599 | 0.000 |
Why?
|
Tennessee | 1 | 1970 | 117 | 0.000 |
Why?
|
Skin | 1 | 1984 | 4364 | 0.000 |
Why?
|
Biological Assay | 1 | 1973 | 652 | 0.000 |
Why?
|
Immune Sera | 1 | 1970 | 641 | 0.000 |
Why?
|
Dental Caries | 1 | 1973 | 415 | 0.000 |
Why?
|
Intracranial Aneurysm | 1 | 1978 | 1197 | 0.000 |
Why?
|
Dysentery, Bacillary | 1 | 1969 | 75 | 0.000 |
Why?
|
New Jersey | 1 | 1968 | 290 | 0.000 |
Why?
|
Periodicity | 1 | 1969 | 363 | 0.000 |
Why?
|
Research Design | 1 | 1982 | 5987 | 0.000 |
Why?
|
Pneumococcal Infections | 1 | 1969 | 497 | 0.000 |
Why?
|
Epilepsy | 1 | 1978 | 3310 | 0.000 |
Why?
|
Influenza Vaccines | 1 | 1969 | 738 | 0.000 |
Why?
|
History, 20th Century | 1 | 1969 | 2740 | 0.000 |
Why?
|
Vaccines | 1 | 1969 | 822 | 0.000 |
Why?
|
Influenza, Human | 1 | 1969 | 1479 | 0.000 |
Why?
|